Brain Storms
The race to unlock the mysteries of Parkinson’s
-
- £7.99
-
- £7.99
Publisher Description
'An excellent grasp on the science...but it is as a human story that the book is most compelling...' TLS
Seven million people worldwide suffer from Parkinson's, with more men having the disease than women. Yet it remains an enigma, with doctors, researchers and patients hunting for a cure. In Brain Storms the award-winning journalist and veteran TV producer, Jon Palfreman, tells their stories, stories that take on a particular urgency since he himself has been diagnosed with the illness.
Palfreman chronicles how scientists have laboured to crack the mystery of what was once called the 'shaking palsy', from the earliest clinical descriptions to the cutting edge of molecular neuroscience. He charts the victories and setbacks of a massive international effort to get the better of the disease, referred to as one of the best windows into the brain itself.
Brain Storms is also a profoundly personal investigation into Palfreman's own struggles and those of others living with Parkinson's.
The race is on to stop or reverse conditions like Parkinson's and Alzheimer's. Brain Storms is the long-overdue, riveting detective story of that race, and a passionate, insightful account of the lives of those affected.
PUBLISHERS WEEKLY
Award-winning journalist Palfreman's fast-paced, captivating, and crisp narrative of patients, doctors, and researchers is part scientific investigation, part medical detective story, and part memoir, and it opens wide a window into the world of Parkinson's. He introduces readers to James Parkinson, who in 1817 offered the first clinical description of the disease; Jean-Martin Charcot, who accurately described the signs and symptoms of what appeared to be a movement disorder; Constantin Tretiakoff, who demonstrated that the disease was caused by damage to the substantia nigra portion of the brain; and Frederick Lewy, who discovered the pathological hallmarks of Parkinson's. Palfreman, who was diagnosed with the disease during his research, investigates drug therapies, such as the routine L-dopa therapy initiated in the 1960s and still used frequently today, and experimental drugs such as NPT088, which has yet to be approved by the FDA. There are more than seven million Parkinson's sufferers worldwide and Palfreman shares some of their stories, including that of dancer Pam Quinn, who has learned to "trick" her symptoms and teaches her methods to other Parkinson's patients. He reminds readers that a diagnosis of Parkinson's is a life sentence, but Palfreman remains optimistic about what new discoveries may be able to offer Parkinson's patients.